Do measures used in studies of anxiety disorders reflect activities and participation as defined in the WHO International Classification of Functioning, Disability and Health?

Clinical Rehabilitation

Volumn 25, Issue 7, 2011, Pages 659-671

  Brütt, Anna Levke ^a   Schulz, Holger ^a   Koch, Uwe ^a   Andreas, Sylke ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Activities of daily living; Anxiety; Biopsychosocial model; Measurement instrument

Indexed keywords

ANXIETY DISORDER; CLASSIFICATION; COMPARATIVE STUDY; CONVALESCENCE; DAILY LIFE ACTIVITY; DISABILITY; DISABLED PERSON; FEMALE; GERMANY; HEALTH STATUS; HUMAN; HUMAN RELATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; PATIENT PARTICIPATION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SOCIAL BEHAVIOR; STATISTICS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ACTIVITIES OF DAILY LIVING; ANXIETY DISORDERS; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; GERMANY; HEALTH STATUS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERPERSONAL RELATIONS; MALE; PATIENT PARTICIPATION; PROGNOSIS; RECOVERY OF FUNCTION; SENSITIVITY AND SPECIFICITY; SOCIAL BEHAVIOR; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 80052688666     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215510396739     Document Type: Article

References (68)

1. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic, second edition. New York: Guilford Press, 2002.
2. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 21-27.
3. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K and Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424.
4. WHO. The World Health Report 2001 - Mental health: new understanding, new hope. Geneva: World Health Organization. 2001.
5. Alonso J, Angermeyer MC, Bernert S, et al. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 38-46.
6. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ and Stein DJ. Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology 2003; 36: 255-262. (Pubitemid 37323501)
7. Mendlowicz MV and Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157: 669-682. (Pubitemid 30249642)
8. Pollack MH, Endicott J, Liebowitz M, et al. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res 2008; 42: 1042-1049.
9. Quilty LC, Van Ameringen M, Mancini C, Oakman J and Farvolden P. Quality of life and the anxiety disorders. J Anxiety Disord 2003; 17: 405-426. (Pubitemid 41123081)
10. Rapaport MH, Clary C, Fayyad R and Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 2005; 162: 1171-1178. (Pubitemid 40770701)
11. Kennedy BL, Lin Y and Schwab JJ. Work, social, and family disabilities of subjects with anxiety and depression. South Med J 2002; 95: 1424-1427. (Pubitemid 36207432)
12. Linden M and Muschalla B. Anxiety disorders and workplace-related anxieties. J Anxiety Disord 2007; 21: 467-474. (Pubitemid 46401168)
13. Waghorn G, Chant D, White P and Whiteford H. Disability, employment and work performance among people with ICD-10 anxiety disorders. Aust N Z J Psychiatry 2005; 39: 55-66. (Pubitemid 40277435)
14. Harter MC, Conway KP and Merikangas KR. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313-320. (Pubitemid 38075973)
15. Lepine JP. Epidemiology, burden, and disability in depression and anxiety. J Clin Psychiatry 2001; 62(suppl 13): 4-10; discussion 1-2.
16. Murphy JM, Horton NJ, Laird NM, Monson RR, Sobol AM and Leighton AH. Anxiety and depression: a 40-year perspective on relationships regarding prevalence, distribution, and comorbidity. Acta Psychiatr Scand 2004; 109: 355-375. (Pubitemid 38491282)
17. Zimmerman M, McDermut W and Mattia JI. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. Am J Psychiatry 2000; 157: 1337-1340. (Pubitemid 30659823)
18. Rodriguez BF, Bruce SE, Pagano ME and Keller MB. Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord 2005; 19: 752-766. (Pubitemid 41074946)
19. Sareen J, Jacobi F, Cox BJ, Belik SL, Clara I and Stein MB. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Arch Intern Med 2006; 166: 2109-2116. (Pubitemid 44631399)
20. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res 2003; 12: 34-43. (Pubitemid 36675446)
21. Stein MB, Roy-Byrne PP, Craske MG, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care 2005; 43: 1164-1170. (Pubitemid 43012172)
22. Fehm L, Pelissolo A, Furmark T and Wittchen HU. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 2005; 15: 453-462. (Pubitemid 40949552)
23. Hoffman DL, Dukes EM and Wittchen H-U. Human and economic burden of generalized anxiety disorder. Depression Anxiety 2008; 25: 72-90. (Pubitemid 351213928)
24. Wittchen HU. Generalized anxiety disorder: prevalence, burden, and cost to society. Depression Anxiety 2002; 16: 162-171.
25. Barlow DH, Allen LB and Basden SL. Psychosocial treatments for panic disorders, phobias, and generalized anxiety disorder. In: Nathan PEG, Jack M (eds) A guide to treatments that work, third edition. New York: Oxford University Press, 2007, pp.351-394.
26. Shearer SL. Recent advances in the understanding and treatment of anxiety disorders. Prim Care 2007; 34: 475-504, v-vi.
27. Fava GA, Ruini C, Rafanelli C, et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom 2005; 74: 26-30. (Pubitemid 40091415)
28. Linden M, Zubraegel D, Baer T, Franke U and Schlattmann P. Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study). Psychother Psychosom 2005; 74: 36-42. (Pubitemid 40091417)
29. Iyer SN, Rothmann TL, Vogler JE and Spaulding WD. Evaluating outcomes of rehabilitation for severe mental illness. Rehabil Psychol 2005; 50: 43-55. (Pubitemid 40344140)
30. Sanderson K, Andrews G and Jelsma W. Disability measurement in the anxiety disorders: comparison of three brief measures. J Anxiety Disord 2001; 15: 333-344. (Pubitemid 32594869)
31. WHO. ICF: International classification of functioning, disability and health. Geneva: World Health Organization, 2001.
32. MacDonald-Wilson KL and Nemec PB. The International Classification of Functioning, Disability and Health (ICF) in psychiatric rehabilitation. Rehabil Educ 2005; 19: 159-176.
33. WHO. Tenth revision of the international classification of diseases, Chapter V(F): Mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1993.
34. Reed GM, Lux LB, Bufka LF, et al. Operationalizing the International Classification of Functioning, Disability and Health in clinical settings. Rehabil Psychol 2005; 50: 122-131. (Pubitemid 40770593)
35. Perini SJ, Slade T and Andrews G. Generic effectiveness measures: sensitivity to symptom change in anxiety disorders. J Affect Disord 2006; 90: 123-130. (Pubitemid 43183520)
36. WHO. World Health Organization Disability Assessment Schedule (WHODAS II). Geneva: World Health Organization, 2000.
37. Cieza A, Ewert T, Ustun TB, Chatterji S, Kostanjsek N and Stucki G. Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med 2004; 44: 9-11. (Pubitemid 39307105)
38. Kesselring J, Coenen M, Cieza A, Thompson A, Kostanjsek N and Stucki G. Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler 2008; 14: 252-254. (Pubitemid 351639636)
39. Tschiesner U, Cieza A, Rogers SN, et al. Developing core sets for patients with head and neck cancer based on the International Classification of Functioning, Disability and Health (ICF). Eur Arch Otorhinolaryngol 2007; 264: 1215-1222. (Pubitemid 350194838)
40. Brach M, Cieza A, Stucki G, et al. ICF core sets for breast cancer. J Rehabil Med 2004; 44(suppl): 121-127. (Pubitemid 39307121)
41. Ruof J, Cieza A, Wolff B, et al. ICF core sets for diabetes mellitus. J Rehabil Med 2004; 44(suppl): 100-106. (Pubitemid 39307118)
42. Stucki G, Cieza A, Geyh S, et al. ICF core sets for rheumatoid arthritis. J Rehabil Med 2004; 44(suppl): 87-93. (Pubitemid 39307116)
43. Brockow T, Wohlfahrt K, Hillert A, et al. Identifying the concepts contained in outcome measures of clinical trials on depressive disorders using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 2004; 44(suppl): 49-55. (Pubitemid 39307111)
44. Cieza A, Chatterji S, Andersen C, et al. ICF core sets for depression. J Rehabil Med 2004; 44(suppl): 128-134. (Pubitemid 39307122)
45. Watson RJ and Richardson PH. Identifying randomized controlled trials of cognitive therapy for depression: comparing the efficiency of Embase, Medline and PsycINFO bibliographic databases. Br J Med Psychol 1999; 72: 535-542. (Pubitemid 30018995)
46. Dickersin K, Scherer R and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994; 309: 1286-1291. (Pubitemid 24340510)
47. APA. Diagnostic and statistical manual of mental disorders, revised fourth edition. Washington, DC: American Psychiatric Association, 1994.
48. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B and Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med 2005; 37: 212-218. (Pubitemid 41025328)
49. Turner SM, Beidel DC and Dancu CV. SPAI - Social Phobia & Anxiety Inventory: manual. Toronto: Multi-Health Systems, 1996.
50. Guy W (ed.) ECDEU assessment manual for psychophar-macology. Rockville, MD: US Department of Health, Education, and Welfare, 1976.
51. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
52. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
53. Heimberg RG, Horner KJ, Juster HR, et al. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med 1999; 29: 199-212. (Pubitemid 29034537)
54. Sheehan DV, Harnett-Sheehan K and Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996; 11(suppl 3): 89-95. (Pubitemid 26373761)
55. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH and Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974; 19: 1-15.
56. Marks IM and Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther 1979; 17: 263-267. (Pubitemid 10232022)
57. Weissman MM and Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976; 33: 1111-1115.
58. Frisch MB, Cornell J, Villanueva M and Retzlaff PJ. Clinical validation of the quality of life inventory: a measure of life satisfation for use in treatment planning and outcome assessment. Psychol Assess 1992; 4: 92-101.
59. Ware JE. SF-36 health survey: manual and interpretation guide, second edition. Boston, MA: The Health Institute, New England Medical Center, 1997.
60. WHO. Disability assessment schedule II. Geneva: World Health Organization, 2000.
61. Baron S and Linden M. The role of the 'International Classification of Functioning, Disability and Health, ICF' in the description and classification of mental disorders. Eur Arch Psychiatry Clin Neurosci 2008; 258(suppl 15): 81-85.
62. Tenorio-Martinez R, del Carmen Lara-Munoz M, Medina-Mora ME, et al. Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 377-384.
63. Cieza A and Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005; 14: 1225-1237. (Pubitemid 40895746)
64. Dijkers MP, Whiteneck G and El-Jaroudi R. Measures of social outcomes in disability research. Arch Phys Med Rehabil 2000; 81(suppl 2): S63-S80.
65. Perenboom RJ and Chorus AM. Measuring participation according to the International Classification of Functioning, Disability and Health (ICF). Disabil Rehabil 2003; 25: 577-587. (Pubitemid 36806191)
66. Resnik L and Plow MA. Measuring participation as defined by the International Classification of Functioning, Disability and Health: an evaluation of existing measures. Arch Phys Med Rehabil 2009; 90: 856.
67. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
68. Jelsma J. Use of the International Classification of Functioning, Disability and Health: a literature survey. J Rehabil Med 2009; 41: 1-12.